Last reviewed · How we verify
Licensed DTPa containing vaccine — Competitive Intelligence Brief
phase 2
Inactivated whole-cell vaccine
Vaccines
Biologic
Live · refreshed every 30 min
Target snapshot
Licensed DTPa containing vaccine (Licensed DTPa containing vaccine) — GlaxoSmithKline. Stimulates the immune system to produce antibodies against diphtheria, tetanus, and pertussis toxins
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Licensed DTPa containing vaccine TARGET | Licensed DTPa containing vaccine | GlaxoSmithKline | phase 2 | Inactivated whole-cell vaccine |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Inactivated whole-cell vaccine class)
- GlaxoSmithKline · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Licensed DTPa containing vaccine CI watch — RSS
- Licensed DTPa containing vaccine CI watch — Atom
- Licensed DTPa containing vaccine CI watch — JSON
- Licensed DTPa containing vaccine alone — RSS
- Whole Inactivated whole-cell vaccine class — RSS
Cite this brief
Drug Landscape (2026). Licensed DTPa containing vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/licensed-dtpa-containing-vaccine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab